The Institut de la Vision and Iris Pharma Join Forces to Strengthen the Bond between the Private and Public Sectors, and between Industry and Academic Research

NICE, France--(BUSINESS WIRE)--The Institut de la Vision, a research center exclusively dedicated to eye diseases, has been the industry's benchmark on vision-related issues since its opening in March 2008. Consequently, it attracts a large number of industrialists looking to test the therapeutic effectiveness of their molecules intended to fight blindness. Thus, Iris Pharma took the logical step of joining forces with the Institut, with several objectives in mind: encourage industrial/academic cooperation, develop research programs and adapt certain specific procedures to the industrial field.
MORE ON THIS TOPIC